Skip to content

Multinational Survey of Epidemiology, Morbidity, and Outcomes in Intracerebral Hemorrhage

Multinational Survey of Epidemiology, Morbidity, and Outcomes in Intracerebral Hemorrhage (MNEMONICH)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02567162
Acronym
MNEMONICH
Enrollment
40
Registered
2015-10-02
Start date
2015-11-30
Completion date
2016-08-31
Last updated
2016-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intracerebral Hemorrhage

Keywords

Intracerebral hemorrhage, Hemorrhagic stroke, Intraparenchymal hemorrhage, Cerebrovascular disease, Stroke

Brief summary

The aim of this project is development of a comprehensive, prospective, multinational, multicenter, hospital-based, data repository for patients with intracerebral hemorrhage.

Detailed description

MNEMONICH is a disease-specific registry of prospectively collected data obtained from the integration and harmonization of preexisting single-center data sets. It was formed to provide clinician-scientists around the world a comprehensive database to direct future studies toward better understanding of ICH. MNEMONICH will help examine global variability in the prevalence of ICH and identify research priorities. New data for MNEMONICH will be prospectively collected on a wide range of features including demographics, medical history, dates and times of symptom onset, presentation symptoms, hemodynamic signs, initial and chronic medical therapy, diagnostic imaging, laboratory and genetic analyses, pathological data, and surgical and medical management. Future research will be based upon ad hoc analysis of this data.

Interventions

None listed

Sponsors

Centre for Cardiovascular Medicine and Cerebrovascular Disease Prevention
CollaboratorUNKNOWN
Hospital Interzonal de Agudos San Juan Bautista
CollaboratorOTHER
Maastricht University Medical Center
CollaboratorOTHER
University of Western Ontario, Canada
CollaboratorOTHER
Northern Care Alliance NHS Foundation Trust
CollaboratorOTHER
University of Manchester
CollaboratorOTHER
University of Rostock
CollaboratorOTHER
University of Medicine and Pharmacy Craiova
CollaboratorOTHER
San Camillo de' Lellis General Hospital
CollaboratorOTHER
Azienda USL Reggio Emilia - IRCCS
CollaboratorOTHER_GOV
University of Central Florida
CollaboratorOTHER
Manchester Metropolitan University
CollaboratorOTHER
The University of Texas Health Science Center at San Antonio
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diagnosis of spontaneous intracerebral hemorrhage (ICH) met by clinical and imaging criteria * Age 18 and above * Able to consent

Exclusion criteria

* ICH due to trauma * ICH due to vascular malformation or aneurysm * ICH due to brain tumor * ICH due to underlying infectious lesion (e.g., abscess)

Design outcomes

Primary

MeasureTime frame
Modified Rankin Scale score90 days

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026